Stocks and Investing
Stocks and Investing
Mon, May 13, 2024
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Gil Blum Reiterated (TCRX) at Strong Buy and Held Target at $11 on, May 13th, 2024
Gil Blum of Needham, Reiterated "TScan Therapeutics, Inc." (TCRX) at Strong Buy and Held Target at $11 on, May 13th, 2024.
Gil has made no other calls on TCRX in the last 4 months.
There are 3 other peers that have a rating on TCRX. Out of the 3 peers that are also analyzing TCRX, 0 agree with Gil's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Gil
- David Nierengarten of "Wedbush" Reiterated at Buy and Held Target at $10 on, Tuesday, April 23rd, 2024
- Peter Lawson of "Barclays" Maintained at Buy with Increased Target to $9 on, Thursday, March 7th, 2024
- Andrew Fein of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $15 on, Thursday, March 7th, 2024
Contributing Sources